Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium

Vaccine

Volumn 30, Issue 46, 2012, Pages 6573-6577

  D'Hauwers, K W M ^a   Depuydt, C E ^b   Bogers, J J ^b,c   Noel, J C ^d   Delvenne, P ^e   Marbaix, E ^f   Donders, A R T ^a   Tjalma, W A A ^g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sonic Healthcare Benelux ^*  (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

HPV; Lichen sclerosus; Men; Penile cancer

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; BELGIUM; CANCER INVASION; CANCER PREVENTION; CANCER RISK; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; INFECTION RISK; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; DNA, VIRAL; GENOTYPE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84866983663     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.034     Document Type: Article

References (34)

1. Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M., et al. Cancer incidence in five continents 2007, IARC Scientific Publications, Lyon.
2. Parkin D.M., Bray F. Chapter 2: The burden of HPV related cancers. Vaccine 2006, Suppl. 3:S11-S25.
3. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
4. Rubin M.A., Kleter B., Zhou M., Ayala G., Cubilla A.L., Quint W.G., et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001, 159(4):1211-1218.
5. Backes D.M., Kurman R.J., Pimenta J.M., Smith J.S. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009, 20:449-457.
6. Muñoz N., Castellsagué X., de González A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24S3:S1-S10.
7. Bleeker M.C.G., Heideman D.A.M., Snijders P.J.F., Horenblas S., Dillner J., Meijer C.J.L.M. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009, 27(2):141-150.
8. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005, 116(4):606-616.
9. Gross G., Pfister H. Role of human papillomavirus in penile cancer: penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 2004, 193(1):35-44.
10. Nasca M.R., Innocenzi D., Micali G. Association of penile lichen sclerosus and oncogenic human papillomavirus infection. Int J Dermatol 2006, 45(6):681-683.
11. Cubilla A.L., Velazquez E.F., Young R.H. Epithelial lesions associated with invasive penile squamous cell carcinoma: a pathologic study of 288 cases. Int J Surg Pathol 2004, 12(4):351-364.
12. Depuydt C.E., Benoy I.H., Bailleul E.J., Vandepitte J., Vereecken A.J., Bogers J.J. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 2006, 17(6):374-381.
13. Micalessi I.M., Boulet G.A., Bogers J.J., Benoy I.H., Depuydt C.E. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med 2012, 50:655-661.
14. Boulet G.A., Horvath C.A., Berghmans S., Moeneclaey L.M., Duys I.S., Arbyn M., et al. Cervical cytology biobanking: quality of DNA from archival cervical Pap-stained smears. J Clin Pathol 2008, 61(5):637-641.
15. Miralles-Guri C., Bruni L., Cubilla A.L., Castellsagué X., Bosch F.X., de Sanjosé S. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009, 62(10):870-878.
16. Pascual A., Pariente M., Godinez J.M., Sánchez-Prieto R., Atienzar M., Segura M., et al. High prevalence of human papillomavirus 16 in penile carcinoma. Histol Histopathol 2007, 22(2):177-183.
17. Senba M., Kumatori A., Fujita S., Jutavijittum P., Yousukh A., Moriuchi T., et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol 2006, 78(10):1341-1346.
18. Picconi M.A., Eiján A.M., Distéfano A.L., Pueyo S., Alonio L.V., Gorostidi S., et al. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol 2000, 61(1):65-69.
19. Dorfman S., Cavazza M., Cardozo J. Penile cancer associated with so-called low-risk human papilloma virus. Report of five cases from rural Venezuela. Trop Doct 2006, 36(4):232-233.
20. Pannone G., Rodolico V., Santoro A., Lo Muzio L., Franco R., Botti G., et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization. Infect Agent Cancer 2012, 7:4.
21. Krustrup D., Helle Lone J., Van den Brule A.J.C., Frisch M. Histological characteristics of human papilloma-virus-positive and-negative invasive and in situ squamous cell tumours of the penis. Int J Exp Pathol 2009, 90:182-189.
22. Muneer A., Kayes O., Ahmed H.U., Arya M., Minhas S. Molecular prognostic factors in penile cancer. World J Urol 2009, 27(2):161-167.
23. Lont A.P., Kroon B.K., Horenblas S., Gallee M.P., Berkhof J., Meijer C.J., et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 2006, 119(5):1078-1081.
24. Bezerra A.L., Lopes A., Santiago G.H., Ribeiro K.C., Latorre M.R., Villa L.L. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001, 91(12):2315-2321.
25. Perceau G., Derancourt C., Clavel C., Durlach A., Pluot M., Lardennois B., et al. Lichen sclerosus is frequently present in penile squamous cell carcinomas but is not always associated with oncogenic human papillomavirus. Br J Dermatol 2003, 148(5):934-938.
26. Heideman D.A., Waterboer T., Pawlita M., Delis-van Diemen P., Nindl I., Leijte J.A., et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 2007, 25(29):4550-4556.
27. van de Nieuwenhof H.P., van Kempen L.C., de Hullu J.A., Bekkers R.L., Bulten J., Melchers W.J., et al. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev 2009, 18(7):2061-2067.
28. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., Nambooze S. Trends in cancer incidence in Kyadondo County: Uganda, 1960-1997. Br J Cancer 2000, 82(9):1585-1592.
29. Kreuter A., Brockmeyer N.H., Weissenborn S.J., Gambichler T., Stücker M., Altmeyer P., et al. Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol 2008, 128(9):2316-2324.
30. Brotherton J.M., Fridman M., May C.L., Chappell G., Saville A.M., Gertig D.M. Early effect of the HPV vaccination program on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011, 377(9783):2085-2092.
31. Donovan B., Franklin N., Guy R., Grulich A.E., Regan D.G., Ali H., et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011, 11(1):39-44.
32. Hernandez B.Y., Wilkens L.R., Zhu X., McDuffie K., Thompson P., Shvetsov Y.B., et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008, 197(6):787-794.
33. Hernandez B.Y., Shvetsov Y.B., Goodman M.T., Wilkens L.R., Thompson P., Zhu X., et al. Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis 2010, 201:1340-1342.
34. Madsen B.S., van den Brule A.J., Jensen H.L., Wohlfahrt J., Frisch M. Risk factors for squamous cell carcinoma of the penis: population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 2008, 17(10):2683-2691.